Status:
COMPLETED
Comparison of Infusion Paracetamol Protocols in PDA
Lead Sponsor:
Ankara University
Conditions:
Patent Ductus Arteriosus in Preterm Infants
Eligibility:
All Genders
Up to 1 years
Brief Summary
The aim of this study was to evaluate the effect of paracetamol on patent ductus arteriosus (PDA) closure and clinical outcomes in preterm infants when used as standard intermittent bolus and continuo...
Detailed Description
Demographic and clinical features Perinatal variables were recorded for all infants, including GA, BW, sex, APGAR scores (at 1 and 5 minutes), prenatal steroids, pre- and post-treatment alanine aminot...
Eligibility Criteria
Inclusion
- birth weight (BW) ≤1500 g and gestational age (GA) ≤32 weeks at birth
Exclusion
- birth weight (BW) \>1500 g and gestational age (GA) \>32 weeks at birth
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 6 2020
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04469413
Start Date
January 1 2019
End Date
January 6 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ufuk Cakir
Ankara, Turkey (Türkiye), 06130